NIH-funded research NIH-funded research

Using memantine and exercise to help with memory problems after breast cancer treatment

Official title: Memantine and Exercise for Chemotherapy-Related Cognitive Decline in Patients with Breast Cancer

Funded at Univ of North Carolina Chapel Hill · NIH-10865172 · Data updated 2026-11-12

This study is looking at how taking memantine along with an exercise program can help breast cancer patients who are experiencing memory and thinking problems due to chemotherapy, and it aims to find out if this combination really makes a difference.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startSeptember 10, 2024
Project endJune 30, 2029
Funding year2024
Award (this year)$181,626
NIH project number1K23AG086604-01
Project IDNIH-10865172 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are breast cancer patients experiencing cognitive decline related to their chemotherapy treatment.

Less likely to help

Patients who are not undergoing chemotherapy or those with pre-existing severe cognitive impairments may not benefit from this research.

What this research studies

This research investigates the effects of memantine, a medication, combined with an exercise program on cognitive decline related to chemotherapy in breast cancer patients. The study will involve a randomized controlled trial with three groups: one receiving both memantine and exercise, another receiving memantine alone, and a third receiving a placebo. The goal is to assess how well this combination can improve cognitive function and address biomarkers associated with cognitive decline. Participants will also provide feedback on the feasibility and acceptability of the treatment during their chemotherapy.

Why it matters

Potential benefit: If successful, this research could provide a new approach to prevent or treat cognitive decline in breast cancer patients undergoing chemotherapy.

How similar studies have gone: Previous research has shown promising results using exercise and cognitive interventions in cancer patients, but this specific combination of memantine and exercise is novel.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Nakamura, Zev — Univ of North Carolina Chapel Hill
  • Study coordinator: Nakamura, Zev

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.